CD19 and neoplasm: Mounting evidence over the past decade suggests that the major TIL subpopulations (CD4, CD8, and CD19/20) encompass varying subset balances with suppressive (pro-tumor) or effector (anti-tumor) phenotypes whose functions are influenced by the surrounding TME10.